Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is N/A as of Tuesday, October 6, 2026.
INTEREST COVERAGE RATIO
N/A
Braveheart Bio, Inc.
Market Cap
$1.42B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.41B
Interest Coverage Ratio
-1753.94x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.42B
Interest Coverage Ratio
0.60x
TTM Avg
0.60x
3Y Avg
0.60x
5Y Avg
0.60x
Market Cap
$1.41B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.40B
Interest Coverage Ratio
7.70x
TTM Avg
6.59x
3Y Avg
5.19x
5Y Avg
6.41x
Market Cap
$1.44B
Interest Coverage Ratio
-8.63x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.44B
Interest Coverage Ratio
30.72x
TTM Avg
19.49x
3Y Avg
15.15x
5Y Avg
21.38x
Market Cap
$1.39B
Interest Coverage Ratio
-11.07x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.45B
Interest Coverage Ratio
1.06x
TTM Avg
1.06x
3Y Avg
1.45x
5Y Avg
1.23x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.42B | N/A | N/A | N/A | N/A |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.41B | -1753.94x | N/A | N/A | N/A |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 0.60x | 0.60x | 0.60x | 0.60x |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | N/A | N/A | N/A | N/A |
| The Pennant Group, Inc. (PNTG)vs › | $1.40B | 7.70x | 6.59x | 5.19x | 6.41x |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | -8.63x | N/A | N/A | N/A |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.44B | 30.72x | 19.49x | 15.15x | 21.38x |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | -11.07x | N/A | N/A | N/A |
| Certara, Inc. (CERT)vs › | $1.45B | 1.06x | 1.06x | 1.45x | 1.23x |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | N/A | N/A | N/A | N/A |
Interest Coverage
N/A
Debt/Equity
N/A
Current Ratio
N/A
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
